20190604 - Chromsystems Industry Workshop - IWT113 - 0730-0830

Chromsystems Industry Workshop

Session Title:

Drugs Screening in Urine Using a Novel Fully Validated LCMS Assay

Presenters:
Huda Cathum, Chromsystems Instruments & Chemicals GmbH
Joseph Macri, Clinical Pathology, Hamilton General Hospital
Matthew Nichols, McMaster University, Molecular Genetics and Pediatric

Objectives:
At the conclusion of this session, participants will be able to:
1. Our goal is to explain how this Health Canada-approved new assay for the screening and simultaneous quantitation of 108 drugs/metabolites in urine can help clinical laboratories. Special focus will be placed on why and how a commercial assay can provide superior and reliable results with the ultimate goal of exceptional patient care. Data will be compared with immunoassay and GC-MS-based methods. The performance characteristics are described and the quality and regulatory background will be discussed.

Question Title

1. Please rate the Session by circling the appropriate number:
Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree

	1	2	3	4	5
Sufficient time was allowed for audience participation/active learning	Sufficient time was allowed for audience participation/active learning 1	Sufficient time was allowed for audience participation/active learning 2	Sufficient time was allowed for audience participation/active learning 3	Sufficient time was allowed for audience participation/active learning 4	Sufficient time was allowed for audience participation/active learning 5
The facilities were satisfactory.	The facilities were satisfactory. 1	The facilities were satisfactory. 2	The facilities were satisfactory. 3	The facilities were satisfactory. 4	The facilities were satisfactory. 5
The session was free from commercial bias	The session was free from commercial bias 1	The session was free from commercial bias 2	The session was free from commercial bias 3	The session was free from commercial bias 4	The session was free from commercial bias 5
Overall, I would rate this Symposium as excellent	Overall, I would rate this Symposium as excellent 1	Overall, I would rate this Symposium as excellent 2	Overall, I would rate this Symposium as excellent 3	Overall, I would rate this Symposium as excellent 4	Overall, I would rate this Symposium as excellent 5

Question Title

2. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Huda Cathum, Chromsystems Instruments & Chemicals GmbH

	1	2	3	4	5
Clarity of	Clarity of 1	Clarity of 2	Clarity of 3	Clarity of 4	Clarity of 5
Met Stated Objectives	Met Stated Objectives 1	Met Stated Objectives 2	Met Stated Objectives 3	Met Stated Objectives 4	Met Stated Objectives 5
Balanced & Unbiased	Balanced & Unbiased 1	Balanced & Unbiased 2	Balanced & Unbiased 3	Balanced & Unbiased 4	Balanced & Unbiased 5
Relevant to Practice Overall	Relevant to Practice Overall 1	Relevant to Practice Overall 2	Relevant to Practice Overall 3	Relevant to Practice Overall 4	Relevant to Practice Overall 5
Time for Active Learning	Time for Active Learning 1	Time for Active Learning 2	Time for Active Learning 3	Time for Active Learning 4	Time for Active Learning 5

Question Title

3. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Joseph Macri, Clinical Pathology, Hamilton General Hospital

	1	2	3	4	5
Clarity of	Clarity of 1	Clarity of 2	Clarity of 3	Clarity of 4	Clarity of 5
Met Stated Objectives	Met Stated Objectives 1	Met Stated Objectives 2	Met Stated Objectives 3	Met Stated Objectives 4	Met Stated Objectives 5
Balanced & Unbiased	Balanced & Unbiased 1	Balanced & Unbiased 2	Balanced & Unbiased 3	Balanced & Unbiased 4	Balanced & Unbiased 5
Relevant to Practice Overall	Relevant to Practice Overall 1	Relevant to Practice Overall 2	Relevant to Practice Overall 3	Relevant to Practice Overall 4	Relevant to Practice Overall 5
Time for Active Learning	Time for Active Learning 1	Time for Active Learning 2	Time for Active Learning 3	Time for Active Learning 4	Time for Active Learning 5

Question Title

4. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Matthew Nichols, McMaster University, Molecular Genetics and Pediatric

	1	2	3	4	5
Clarity of	Clarity of 1	Clarity of 2	Clarity of 3	Clarity of 4	Clarity of 5
Met Stated Objectives	Met Stated Objectives 1	Met Stated Objectives 2	Met Stated Objectives 3	Met Stated Objectives 4	Met Stated Objectives 5
Balanced & Unbiased	Balanced & Unbiased 1	Balanced & Unbiased 2	Balanced & Unbiased 3	Balanced & Unbiased 4	Balanced & Unbiased 5
Relevant to Practice Overall	Relevant to Practice Overall 1	Relevant to Practice Overall 2	Relevant to Practice Overall 3	Relevant to Practice Overall 4	Relevant to Practice Overall 5
Time for Active Learning	Time for Active Learning 1	Time for Active Learning 2	Time for Active Learning 3	Time for Active Learning 4	Time for Active Learning 5

Question Title

5. As a result of attending this session, I am planning to: (please check one)

	YES	NO
a) Discuss the session with my colleagues	a) Discuss the session with my colleagues YES	a) Discuss the session with my colleagues NO
b) Pursue additional learning activities.	b) Pursue additional learning activities. YES	b) Pursue additional learning activities. NO
c) Complete a Personal Learning Project.	c) Complete a Personal Learning Project. YES	c) Complete a Personal Learning Project. NO
d) Not change my practice.	d) Not change my practice. YES	d) Not change my practice. NO
e) Change my practice.	e) Change my practice. YES	e) Change my practice. NO

Question Title

6. Please explain the change you are planning to make or the learning you plan to complete:

Question Title

7. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply)

Medical Expert

Communicator

Collaborator

Manager

Health Advocate

Scholar

Professional

20190604 - Chromsystems Industry Workshop - IWT113 - 0730-0830

Chromsystems Industry Workshop

Question Title

1. Please rate the Session by circling the appropriate number:
Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree

Question Title

2. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Huda Cathum, Chromsystems Instruments & Chemicals GmbH

Question Title

3. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Joseph Macri, Clinical Pathology, Hamilton General Hospital

Question Title

4. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Matthew Nichols, McMaster University, Molecular Genetics and Pediatric

Question Title

5. As a result of attending this session, I am planning to: (please check one)

Question Title

6. Please explain the change you are planning to make or the learning you plan to complete:

Question Title

7. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply)

Question Title

8. General comments about individual speakers

Question Title

9. What topics need to be addressed at future conferences to keep you up to date in your profession?

Question Title

* 1. Please rate the Session by circling the appropriate number:Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree

Question Title

* 2. Please asses the Speaker by circling the appropriate number.Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 OutstandingHuda Cathum, Chromsystems Instruments & Chemicals GmbH

Question Title

* 3. Please asses the Speaker by circling the appropriate number.Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 OutstandingJoseph Macri, Clinical Pathology, Hamilton General Hospital

Question Title

* 4. Please asses the Speaker by circling the appropriate number.Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 OutstandingMatthew Nichols, McMaster University, Molecular Genetics and Pediatric

Question Title

* 5. As a result of attending this session, I am planning to: (please check one)

Question Title

* 6. Please explain the change you are planning to make or the learning you plan to complete:

Question Title

* 7. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply)

Question Title

* 8. General comments about individual speakers

Question Title

* 9. What topics need to be addressed at future conferences to keep you up to date in your profession?

1. Please rate the Session by circling the appropriate number:
Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree

2. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Huda Cathum, Chromsystems Instruments & Chemicals GmbH

3. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Joseph Macri, Clinical Pathology, Hamilton General Hospital

4. Please asses the Speaker by circling the appropriate number.
Rating Scale: 1 Poor, 2 Fair, 3 Good, 4 Very Good, 5 Outstanding
Matthew Nichols, McMaster University, Molecular Genetics and Pediatric

5. As a result of attending this session, I am planning to: (please check one)

6. Please explain the change you are planning to make or the learning you plan to complete:

7. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply)

8. General comments about individual speakers

9. What topics need to be addressed at future conferences to keep you up to date in your profession?